Chinese cell therapy developer NK CellTech has raised nearly 100 million renminbi ($14 million) in an extended series A+++ ...

Lewy body dementia (LBD) remains one of the most overlooked and complex neurodegenerative conditions, but momentum is ...

Sino-American biopharma Ascentage Pharma announced that its proprietary novel Bcl-2 selective inhibitor lisaftoclax (APG-2575 ...

Shares in US biotech Ultragenyx Pharmaceutical (Nasdaq: RARE) and its UK-based partner Mereo BioPharma (Nasdaq: MREO) tumbled ...

The US Food and Drug Administration (FDA) has approved US mRNA specialist Moderna supplemental Biologics License Application ...

French biotech Osivax has published results from a Phase IIa trial showing that its lead candidate OVX836, a broad-spectrum ...

China-based biotech Biocytogen has signed a global licensing agreement with oncology-focused BeOne Medicines (SHA: 688235), ...

The US Food and Drug Administration (FDA) has accepted for review Merck & Co’s New Drug Application (NDA) for ...

The US Food and Drug Administration (FDA) has taken the radical move of publishing more than 200 decision letters, known as ...

The European Commission has approved Tevimbra (tislelizumab), alongside gemcitabine and cisplatin, for the first-line ...

BeOne Medicines - the Sino-American oncology specialist formerly known as BeiGene (SHA: 688235) - has announced that the ...

US pharma major AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation today ...